Literature DB >> 1534539

Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes.

C V Clevenger1, A L Sillman, J Hanley-Hyde, M B Prystowsky.   

Abstract

The neuroendocrine hormone PRL acts as a progression factor during interleukin-2 (IL2) stimulated lymphocyte proliferation. Since the sequential expression of cell cycle regulated genes occurs during this process, we examined the contribution of IL2 and PRL to specific RNA accumulation. Stimulation of the cloned T cell line L2 with IL2 and PRL induced the sequential expression of interferon regulatory factor-1, c-myc, proliferating cell nuclear antigen, thymidine kinase, cyclin B, and histone H3. Stimulation of L2 cells with PRL alone, however, induced only the expression of interferon regulatory factor-1. Depletion of PRL, through the use of an anti-PRL antiserum, inhibited IL2 driven proliferation and the expression of cyclin B and histone H3. These results demonstrate that PRL may regulate T cell proliferation by enhancing the expression of some genes necessary for entry into S-phase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534539     DOI: 10.1210/endo.130.6.1534539

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Modulation of growth factor receptor function by isoform heterodimerization.

Authors:  W P Chang; C V Clevenger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Prolactin and prolactin receptors are expressed and functioning in human prostate.

Authors:  M T Nevalainen; E M Valve; P M Ingleton; M Nurmi; P M Martikainen; P L Harkonen
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 3.  The role of prolactin in the pathogenesis of autoimmune disease.

Authors:  Istvan Berczi
Journal:  Endocr Pathol       Date:  1993-12       Impact factor: 3.943

4.  The effect of prolactin (PRL) on the growth of Toxoplasma gondii tachyzoites in vitro.

Authors:  Katarzyna Dzitko; Justyna Gatkowska; Przemysław Płociński; Bozena Dziadek; Henryka Długońska
Journal:  Parasitol Res       Date:  2010-04-16       Impact factor: 2.289

5.  TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH.

Authors:  S Raiden; E Polack; V Nahmod; M Labeur; F Holsboer; E Arzt
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

6.  Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.

Authors:  W P Chang; Y Ye; C V Clevenger
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

Review 7.  Prolactin as an autocrine/paracrine factor in breast tissue.

Authors:  C V Clevenger; T L Plank
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

8.  Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.

Authors:  Yunfei Wen; Ying Wang; Anca Chelariu-Raicu; Elaine Stur; Yuan Liu; Sara Corvigno; Faith Bartsch; Lauren Redfern; Behrouz Zand; Yu Kang; Jinsong Liu; Keith Baggerly; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2020-07-31       Impact factor: 6.261

9.  Prolactin modulates the naive B cell repertoire.

Authors:  Elena Peeva; Daniel Michael; James Cleary; Jeffrey Rice; Xian Chen; Betty Diamond
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

10.  The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

Authors:  L De Petrocellis; D Melck; A Palmisano; T Bisogno; C Laezza; M Bifulco; V Di Marzo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.